FdaApplication
ANDA 213195
Identifiers
- fda_app_no: ANDA213195
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-07-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALTREXONE | NALTREXONE | 380MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
1 product